Steve Schonfeld’s Organon & Co OGN Stock Holding History

Steve Schonfeld’s Portfolio OGN Stock Details OGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$6.77M	Buy	+500,000	New	+$5.98M	0.02%	537

Other funds holding OGN

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

PCM

Pentwater Capital Management Naples, Florida $16.4B AUM 55.44% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Man Group London, United Kingdom $62.7B AUM 29.77% 1-Year Est. Return

AQR Arbitrage Greenwich, Connecticut $7.02B AUM 31.58% 1-Year Est. Return

Steve Schonfeld's OGN Position: Q2 2026 in Review

Steve Schonfeld sold out of Organon & Co (OGN) in Q2 2026, closing a stake of 52,525 shares — an estimated $628K sold.

Steve Schonfeld first reported a position in OGN in Q4 2021 and held it in 10 quarters. The position peaked at $4.75M in Q3 2025. 627 funds tracked by Wall St. Rank hold OGN as of Q2 2026.

Steve Schonfeld reported no remaining Organon & Co position as of Q2 2026 after selling out during the quarter.
Steve Schonfeld sold 52,525 Organon & Co shares in Q2 2026, an estimated $628K.
Steve Schonfeld first reported a position in Organon & Co in Q4 2021 and held it in 10 quarters.
Steve Schonfeld's Organon & Co position peaked at $4.75M in Q3 2025.
627 funds tracked by Wall St. Rank held Organon & Co as of Q2 2026.

Based on Schonfeld Strategic Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.